VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
9382
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1313
Interactions with Platform & by Email
PARTICIPANTS
281
Unique # Participated
VALIDATIONS
126
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JUL 2020
TABLES
309
PAGES
385
EDITION
5
PRICE
USD $5450
With the Global Economy Walking the Tightrope, It's the Numbers that Help Understand this Uncertain World.
Amid the COVID-19 crisis, the global market for Peptide Therapeutics estimated at US$27.2 Billion in the year 2020, is projected to reach a revised size of US$47 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Innovative, one of the segments analyzed in the report, is projected to record 6.6% CAGR and reach US$28 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Generic segment is readjusted to a revised 10.6% CAGR for the next 7-year period.
The Peptide Therapeutics market in the U.S. is estimated at US$7.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.5 Billion by the year 2027 trailing a CAGR of 12.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.We bring years of research experience to this 5th edition of our report. The 385-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
AbbVie, Inc.; Advanced Accelerator Applications SA; Akashi Therapeutics, Inc.; Amgen, Inc.; Anthera Pharmaceuticals, Inc.; AstraZeneca PLC; Bachem AG; Bristol-Myers Squibb Company; Cardiorentis AG; Corden Pharma International GmbH; Debiopharm Group; Derma Sciences, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Hanmi Pharmaceutical Co., Ltd.; Insmed, Inc.; Ipsen Group; Johnson & Johnson; Lonza Group AG; Mallinckrodt PLC; Merck & Co., Inc.; MolMed S.p.A.; Novartis AG; Novo Nordisk A/S; Nymox Pharmaceutical Corporation; PAR Pharmaceutical Companies, Inc.; PeptiDream Inc.; Pfizer, Inc.; PolyPeptide Group; Radius Health, Inc.; Repligen Corporation; Sanofi SA; SciClone Pharmaceuticals Holding Limited.; Shire PLC; Takeda Pharmaceutical Co., Ltd.; Teva Pharmaceutical Industries Ltd.; The Medicines Company; X-GEN Pharmaceuticals, Inc.; Zealand Pharma A/S; Zydus Cadila
» Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, Other Applications) » Technology (Liquid Phase, Solid Phase, Hybrid Phase) » Type (Innovative, Generic)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Peptide Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Peptide Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Peptide Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Peptide Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Cancer (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025 |
| Cancer (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017 |
| Cancer (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Cardiovascular Disease (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Cardiovascular Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Cardiovascular Disease (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Metabolic Disease (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025 |
| Metabolic Disease (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 |
| Metabolic Disease (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| Respiratory Disease (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Respiratory Disease (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 |
| Respiratory Disease (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Infectious Disease (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Infectious Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Infectious Disease (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Other Applications (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025 |
| Other Applications (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017 |
| Other Applications (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Innovative (Type) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Innovative (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Innovative (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Generic (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Generic (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Generic (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Liquid Phase (Technology) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Liquid Phase (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Liquid Phase (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Solid Phase (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
| Solid Phase (Technology) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Solid Phase (Technology) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Hybrid Phase (Technology) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Hybrid Phase (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Hybrid Phase (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Peptide Therapeutics Market Share (in %) by Company: 2019 & 2025 |
| United States Peptide Therapeutics Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 |
| Peptide Therapeutics Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| United States Peptide Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 |
| Peptide Therapeutics Market in the United States by Type: A Historic Review in US$ Million for 2009-2017 |
| United States Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in US$ Million in the United States by Technology: 2018-2025 |
| United States Peptide Therapeutics Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| United States Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Peptide Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Canadian Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Canadian Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 |
| Canadian Peptide Therapeutics Historic Market Review by Type in US$ Million: 2009-2017 |
| Peptide Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Peptide Therapeutics Market Analysis in Canada in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Canada: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| Canadian Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| JAPAN |
| Japanese Demand Estimates and Forecasts for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| Japanese Peptide Therapeutics Market in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| Japanese Market for Peptide Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 |
| Japanese Peptide Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Japanese Medium & Long-Term Outlook for Peptide Therapeutics Market in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Japan in US$ Million by Technology: 2009-2017 |
| Japanese Peptide Therapeutics Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Demand for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market Review in China in US$ Million by Application: 2009-2017 |
| Chinese Peptide Therapeutics Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Chinese Peptide Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Historic Market Analysis in China in US$ Million by Type: 2009-2017 |
| Chinese Peptide Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Peptide Therapeutics Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025 |
| Chinese Peptide Therapeutics Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in China: Percentage Share Analysis by Technology for 2009, 2019, and 2025 |
| EUROPE |
| Market Facts & Figures |
| European Peptide Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Peptide Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Peptide Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Peptide Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Peptide Therapeutics Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Peptide Therapeutics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| European Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| European Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 |
| Peptide Therapeutics Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 |
| European Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| European Peptide Therapeutics Market Assessment in US$ Million by Technology: 2018-2025 |
| European Peptide Therapeutics Historic Market Review in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| FRANCE |
| Peptide Therapeutics Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Peptide Therapeutics Historic Market Review in US$ Million by Application: 2009-2017 |
| French Peptide Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Peptide Therapeutics Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Peptide Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017 |
| French Peptide Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| French Peptide Therapeutics Market Estimates and Projections in US$ Million by Technology: 2018-2025 |
| French Peptide Therapeutics Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| French Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| GERMANY |
| Peptide Therapeutics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| German Peptide Therapeutics Market in Retrospect in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 |
| German Peptide Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 |
| German Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| German Peptide Therapeutics Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| German Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Demand for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market Review in Italy in US$ Million by Application: 2009-2017 |
| Italian Peptide Therapeutics Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Italian Peptide Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Historic Market Analysis in Italy in US$ Million by Type: 2009-2017 |
| Italian Peptide Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Peptide Therapeutics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025 |
| Italian Peptide Therapeutics Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in Italy: Percentage Share Analysis by Technology for 2009, 2019, and 2025 |
| UNITED KINGDOM |
| United Kingdom Demand Estimates and Forecasts for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| United Kingdom Peptide Therapeutics Market in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| United Kingdom Market for Peptide Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 |
| United Kingdom Peptide Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| United Kingdom Medium & Long-Term Outlook for Peptide Therapeutics Market in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in the United Kingdom in US$ Million by Technology: 2009-2017 |
| United Kingdom Peptide Therapeutics Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| SPAIN |
| Spanish Peptide Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Spanish Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Spanish Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 |
| Spanish Peptide Therapeutics Historic Market Review by Type in US$ Million: 2009-2017 |
| Peptide Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Peptide Therapeutics Market Analysis in Spain in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Spain: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| Spanish Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| RUSSIA |
| Russian Peptide Therapeutics Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Historic Demand Patterns in Russia by Application in US$ Million for 2009-2017 |
| Peptide Therapeutics Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025 |
| Russian Peptide Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 |
| Peptide Therapeutics Market in Russia by Type: A Historic Review in US$ Million for 2009-2017 |
| Russian Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in US$ Million in Russia by Technology: 2018-2025 |
| Russian Peptide Therapeutics Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| Russian Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Peptide Therapeutics Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Peptide Therapeutics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Rest of Europe Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 |
| Peptide Therapeutics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Rest of Europe Peptide Therapeutics Market Assessment in US$ Million by Technology: 2018-2025 |
| Rest of Europe Peptide Therapeutics Historic Market Review in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| ASIA-PACIFIC |
| Asia-Pacific Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Peptide Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
| Asia-Pacific Peptide Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Peptide Therapeutics Historic Market Review in US$ Million by Application: 2009-2017 |
| Asia-Pacific Peptide Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Peptide Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Peptide Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017 |
| Asia-Pacific Peptide Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Asia-Pacific Peptide Therapeutics Market Estimates and Projections in US$ Million by Technology: 2018-2025 |
| Asia-Pacific Peptide Therapeutics Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Asia-Pacific Peptide Therapeutics Historic Market Analysis in US$ Million by Technology: 2009 VS 2019 VS 2025 |
| AUSTRALIA |
| Peptide Therapeutics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Australian Peptide Therapeutics Market in Retrospect in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 |
| Australian Peptide Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 |
| Australian Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Australian Peptide Therapeutics Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Australia: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| Australian Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| INDIA |
| Indian Peptide Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Indian Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Indian Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 |
| Indian Peptide Therapeutics Historic Market Review by Type in US$ Million: 2009-2017 |
| Peptide Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Peptide Therapeutics Market Analysis in India in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in India: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| Indian Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| SOUTH KOREA |
| Peptide Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| South Korean Peptide Therapeutics Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 |
| South Korean Peptide Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2018-2025 |
| South Korean Peptide Therapeutics Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in South Korea by Technology: 2009 VS 2019 VS 2025 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Demand Estimates and Forecasts for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| Rest of Asia-Pacific Peptide Therapeutics Market in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Market for Peptide Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 |
| Rest of Asia-Pacific Peptide Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Medium & Long-Term Outlook for Peptide Therapeutics Market in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Rest of Asia-Pacific in US$ Million by Technology: 2009-2017 |
| Rest of Asia-Pacific Peptide Therapeutics Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| LATIN AMERICA |
| Latin American Peptide Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025 |
| Peptide Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Peptide Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Demand for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market Review in Latin America in US$ Million by Application: 2009-2017 |
| Latin American Peptide Therapeutics Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Latin American Peptide Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017 |
| Latin American Peptide Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Peptide Therapeutics Market Estimates and Forecasts in Latin America in US$ Million by Technology: 2018-2025 |
| Latin American Peptide Therapeutics Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in Latin America : Percentage Analysis by Technology for 2009, 2019, and 2025 |
| ARGENTINA |
| Argentinean Peptide Therapeutics Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Peptide Therapeutics Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Argentinean Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Argentinean Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 |
| Peptide Therapeutics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017 |
| Argentinean Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Argentinean Peptide Therapeutics Market Assessment in US$ Million by Technology: 2018-2025 |
| Argentinean Peptide Therapeutics Historic Market Review in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in Argentina: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| BRAZIL |
| Peptide Therapeutics Quantitative Demand Analysis in Brazil in US$ Million by Application: 2018-2025 |
| Brazilian Peptide Therapeutics Historic Market Review in US$ Million by Application: 2009-2017 |
| Brazilian Peptide Therapeutics Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Peptide Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Peptide Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017 |
| Brazilian Peptide Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Brazilian Peptide Therapeutics Market Estimates and Projections in US$ Million by Technology: 2018-2025 |
| Brazilian Peptide Therapeutics Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Brazilian Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| MEXICO |
| Peptide Therapeutics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Mexican Peptide Therapeutics Market in Retrospect in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 |
| Mexican Peptide Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 |
| Mexican Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Mexican Peptide Therapeutics Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Mexico: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| Mexican Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| REST OF LATIN AMERICA |
| Rest of Latin America Peptide Therapeutics Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2009-2017 |
| Peptide Therapeutics Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025 |
| Rest of Latin America Peptide Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 |
| Peptide Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in US$ Million in Rest of Latin America by Technology: 2018-2025 |
| Rest of Latin America Peptide Therapeutics Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| Rest of Latin America Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| MIDDLE EAST |
| The Middle East Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Peptide Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
| The Middle East Peptide Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Peptide Therapeutics Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| The Middle East Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| The Middle East Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025 |
| The Middle East Peptide Therapeutics Historic Market by Type in US$ Million: 2009-2017 |
| Peptide Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| The Middle East Peptide Therapeutics Market Analysis in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in the Middle East: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| The Middle East Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| IRAN |
| Iranian Demand Estimates and Forecasts for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| Iranian Peptide Therapeutics Market in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025 |
| Iranian Market for Peptide Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017 |
| Iranian Peptide Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Iranian Medium & Long-Term Outlook for Peptide Therapeutics Market in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Iran in US$ Million by Technology: 2009-2017 |
| Iranian Peptide Therapeutics Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| ISRAEL |
| Israeli Peptide Therapeutics Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Peptide Therapeutics Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Israeli Peptide Therapeutics Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Israeli Peptide Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025 |
| Peptide Therapeutics Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017 |
| Israeli Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Israeli Peptide Therapeutics Market Assessment in US$ Million by Technology: 2018-2025 |
| Israeli Peptide Therapeutics Historic Market Review in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in Israel: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| SAUDI ARABIA |
| Saudi Arabian Demand for Peptide Therapeutics in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Market Review in Saudi Arabia in US$ Million by Application: 2009-2017 |
| Saudi Arabian Peptide Therapeutics Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Saudi Arabian Peptide Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025 |
| Peptide Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017 |
| Saudi Arabian Peptide Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Peptide Therapeutics Market Estimates and Forecasts in Saudi Arabia in US$ Million by Technology: 2018-2025 |
| Saudi Arabian Peptide Therapeutics Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market in Saudi Arabia: Percentage Share Analysis by Technology for 2009, 2019, and 2025 |
| UNITED ARAB EMIRATES |
| Peptide Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| United Arab Emirates Peptide Therapeutics Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 |
| United Arab Emirates Peptide Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2018-2025 |
| United Arab Emirates Peptide Therapeutics Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in United Arab Emirates by Technology: 2009 VS 2019 VS 2025 |
| REST OF MIDDLE EAST |
| Peptide Therapeutics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Rest of Middle East Peptide Therapeutics Market in Retrospect in US$ Million by Application: 2009-2017 |
| Peptide Therapeutics Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025 |
| Rest of Middle East Peptide Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017 |
| Rest of Middle East Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Rest of Middle East Peptide Therapeutics Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Peptide Therapeutics Market in Rest of Middle East: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| Rest of Middle East Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| AFRICA |
| African Peptide Therapeutics Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Peptide Therapeutics Historic Demand Patterns in Africa by Application in US$ Million for 2009-2017 |
| Peptide Therapeutics Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025 |
| African Peptide Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025 |
| Peptide Therapeutics Market in Africa by Type: A Historic Review in US$ Million for 2009-2017 |
| African Peptide Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Peptide Therapeutics Market in US$ Million in Africa by Technology: 2018-2025 |
| African Peptide Therapeutics Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| African Peptide Therapeutics Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 46 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com